+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Deep Vein Thrombosis (DVT) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Deep Vein Thrombosis (DVT) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypothalamic Obesity - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypothalamic Obesity - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Dup15q Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Dup15q Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
Atrophic Vaginitis - Pipeline Insight, 2021 - Product Thumbnail Image

Atrophic Vaginitis - Pipeline Insight, 2021

  • Clinical Trials
  • January 2021
  • 60 Pages
  • Global
From
Febrile Neutropenia Market - Product Thumbnail Image

Febrile Neutropenia Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Community Acquired Pneumonia Market - Product Thumbnail Image

Community Acquired Pneumonia Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
From
Opioid Induced Constipation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Opioid Induced Constipation Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Propolis Market 2025-2029 - Product Thumbnail Image

Propolis Market 2025-2029

  • Report
  • May 2025
  • 222 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more